TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
EXEL

Exelixis Inc

Healthcare · Biotechnology

58.40$ -0.2% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet EXEL
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
51.0% 53.8% 78.8% 74.0% 63.1% 53.6% 67.6% 70.1% 52.7% 44.8% 49.8% 50.7%
24.5% 42.6% 25.4% 28.0% 22.1% 14.1% 14.9% 24.7% 16.3% 8.9% 7.4% 17.0%
44.0% 50.3% 70.3% 59.2% 48.7% 45.2% 56.5% 56.1% 42.6% 33.8% 37.7% 37.2%
1.5% 1.6% 6.8% 12.4% 12.6% 6.3% 7.5% 10.8% 7.0% 8.1% 9.0% 10.1%
0.7% 0.8% 0.6% 1.0% 0.7% 0.7% 1.0% 1.1% 1.1% 0.6% 0.8% 0.8%
0.7% 0.4% 0.3% 3.9% 4.0% 2.6% 3.2% 5.7% 3.6%
19.4% 19.2% 10.7% 9.7% 4.5% 3.4% 3.0% 2.4% 2.1% 2.2% 2.2% 2.2%
19.4% 19.2% 10.7% 9.7%
135.0% 131.4% 85.1% 56.5% 9.5% 10.6% 12.1% 15.5% 19.0% 23.1% 23.9% 24.0%
52.4% 15.7% 45.3% 17.6% 7.4% 7.6% 9.6% 12.9% 10.6% 13.4% 13.7% 14.3%
30.3% 125.8% 31.7% 8.8% 4.0% 0.1% 0.1% 0.3% 0.6% 0.9% 0.8%
2.0% 1.9% 1.1% 1.5% 0.8% 0.6% 1.1% 0.9% 1.1% 1.1% 1.3% 1.0%
80.0% 114.8% 0.0% 0.1% 0.9%
-35.0% -31.4% 14.9% 43.5% 90.5% 89.4% 87.9% 84.5% 81.0% 76.9% 76.1% 76.0%
-538.9% -582.8% -331.9% -279.1% -61.9% -29.7% -20.9% -8.3% -1.1% -5.9% -3.3% -2.7%
59.2% 63.0% 41.9% 47.6% 22.0% 16.7% 14.9% 12.3% 10.6% 10.9% 10.0% 9.9%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?